Using Radiological Data to Estimate Ischemic Stroke Severity by Sico, Jason J. et al.
Using Radiological Data to Estimate Ischemic Stroke Severity 
Jason J. Sico, MD;1,2,3 Michael S. Phipps, MD; 4,5;John Concato, MD;3,6,7 Cynthia Brandt, MD, 
MPH; 8 Carolyn K. Wells, MPH;3,7 Albert C. Lo, MD, PhD;9,10 Stephen E. Nadeau, MD;11,12  
Linda S. Williams, MD;13,14 Mark Gorman, MD;15 John L. Boice, MD;17 and Dawn M. Bravata, 
MD;13,16
AFFILIATIONS 
1. Neurology Service, VA Connecticut Healthcare System, West Haven, CT
2. Department of Neurology and Center for NeuroEpidemiological and Clinical
Neurological Research, Yale University School of Medicine, New Haven, CT
3. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
4. Department of Neurology, University of Maryland, Baltimore, Maryland
5. Department of Epidemiology and Public Health, University of Maryland, Baltimore,
Maryland
6. Medicine Service, VA Connecticut Healthcare System, West Haven, CT
7. Clinical Epidemiology Research Center (CERC), VA Connecticut Healthcare System,
West Haven, CT
8. Department of Anesthesiology, Yale University School of Medicine, New Haven, CT
9. Department of  Neurology, Warren Alpert School of Medicine and Departments of
Neurosciences, Community Health, and Engineering at Brown University, Providence,
RI
10. Providence Veterans Administration Medical Center, Providence, RI
11. Neurology Service, Malcolm Randall VA Medical Center, Gainesville, FL
12. Department of Neurology, University of Florida School of Medicine, Gainesville, FL
13. VA Health Services Research and Development (HSR&D) Center for Health Information
and Communication (CHIC) and the HSR&D Stroke Quality Enhancement Research
Initiative (QUERI); Richard L. Roudebush VA Medical Center, Indianapolis, IN
14. Department of Neurology, Indiana University School of Medicine, and Regenstrief
Institute, Indianapolis, IN
15. Department of Neurology, University of Vermont School of Medicine, Burlington, VT
16. Department of Internal Medicine, Indiana University School of Medicine, and
Regenstrief Institute, Indianapolis, IN
17. Medical Service, Boise VA Medical Center
GRANT SUPPORT 
This project was supported by the Department of Veterans Affairs (HSR&D CDA 11-262 and 
Merit IIR-01-10403) and Max Patterson Stroke Research Fund at Yale University. 
CORRESPONDENCE 
Jason J. Sico, MD 
950 Campbell Avenue 
VA Connecticut Healthcare System, Attn: Neurology – 127 
 
This is the author's manuscript of the article published in final edited form as:
Sico, J. J., Phipps, M. S., Concato, J., Brandt, C., Wells, C. K., Lo, A. C., … Bravata, D. M. (2016). Using Radiological 
Data to Estimate Ischemic Stroke Severity. Journal of Stroke and Cerebrovascular Diseases, 25(4), 792–798. 
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.12.002
2 
 
West Haven, CT 06516 
Telephone: (203) 932-5711, X-4724 
Fax: (203) 937-3464 
E-mail: Jason.sico@yale.edu 
RUNNING TITLE                                                                                                                      
Radiographic Predictors of Stroke Severity 
  
3 
 
Goal: Risk-adjusted post-stroke mortality has been proposed for use as a measure of stroke care 
quality. Although valid measures of stroke severity (e.g., the NIH Stroke Scale) are not typically 
available in administrative datasets, radiology reports are often available within electronic health 
records. We sought to examine whether admission head computed tomography data could be 
used estimate stroke severity. 
Materials and Methods:  Using chart review data from a cohort of acute ischemic stroke patients 
(1998-2003), we developed a radiographic measure (Brain Imaging Score) of stroke severity in a 
two-thirds development set and assessed in a one-third validation set. The retrospective NIH 
Stroke Scale was dichotomized as: mild/moderate (<10) and severe (≥10). We compared the 
association of this radiographic score with NIH Stroke Scale and in-hospital mortality at the 
patient-level. 
Findings: Among 1348 stroke patients, 86.5% had abnormal findings on initial head computed 
tomography. The c-statistic for the Brain Imaging Score for modeling severe stroke 
(development, 0.581; validation, 0.579) and in-hospital mortality (development, 0.623; 
validation, 0.678) were generated.   
Conclusion: Although the c-statistics were only moderate, the BIS provide significant risk 
stratification information with a two-variable score. Until administrative data routinely includes a 
valid measure of stroke severity, radiographic data may provide information for use in risk 
adjustment.      
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INTRODUCTION 
Stroke severity is one of the strongest predictors of post-stroke mortality at the patient 
level.(1-3)  The National Institutes of Health Stroke Scale (NIHSS) is a valid and commonly used 
prospective measure of stroke severity.  The addition of the NIHSS to claims-based 30-day acute 
ischemic stroke hospital mortality risk models has been shown to improve model discrimination 
and change mortality performance rankings for hospitals care for Medicare beneficiaries.(4) 
Healthcare organizations, such as the Centers for Medicare and Medicaid Service (CMS), 
routinely use 30-day mortality following acute ischemic stroke to evaluate hospital care 
quality.(5) Unfortunately, the NIHSS is neither documented in routine clinical practice for all 
stroke patients and nor is currently readily accessible in administrative data.  
Predicting stroke severity using commonly gathered and readily accessible data from 
ischemic stroke patients could be useful for risk adjustment of post-stroke mortality. The 
retrospective NIHSS (rNIHSS) can be constructed from chart review data with excellent 
reproducibility and validity;(3) however, the neurological examination data needed to construct 
an rNIHSS are also not available in administrative data. Even within the robust Department of 
Veterans Affairs (VA) electronic medical record system, the rNIHSS cannot be efficiently 
extracted from chart data. In contrast, brain imaging is obtained routinely during the evaluation 
of patients with stroke.(6) Certain findings on initial head computed tomography (CT; e.g., 
hypodensity) have been associated with poor stroke outcomes (e.g., stroke severity and 
mortality).(7-11) Radiology reports of brain imaging studies are readily accessible across VA 
Medical Centers (VAMC), and therefore could be text-mined, potentially providing a means for 
obtaining information about stroke severity.   
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We sought to examine whether admission brain imaging data could be used to estimate 
stroke severity (based on the rNIHSS). As a secondary analysis, we evaluated the association of 
radiographic data with in-hospital mortality. We hypothesized that we could identify 
radiographic features that were associated with severe strokes and that the presence of those 
radiographic features would be associated with an increased risk of in-hospital mortality. 
Materials and Methods 
Patients and Setting 
 This study is a secondary analysis of medical record review data from the Quality 
Evaluation in Stroke and Transient Ischemic Attack (TIA; QUEST) study.(12) Briefly, this 
retrospective cohort included patients who were admitted with ischemic stroke or TIA at any of 
three VA or two non-VA hospitals, during the years 1998-2003, if they had a neurological 
symptom onset within 2 days of admission, had a neurological deficit on admission (rNIHSS ≥ 
2), and were at least 18-years old. Patients were excluded from the QUEST study if they were 
residing in a skilled nursing facility at the time of stroke symptom onset, were already admitted 
to the hospital at the time of stroke symptom onset, were transferred from another acute care 
facility, or were not admitted to the hospital. For this study, we restricted the analysis to stroke 
patients, and also excluded patients who were: without brain imaging (n=1) and whose brain 
imaging results were not known (n=3). Since most patients receive a head CT at initial 
presentation over other imaging modalities, we excluded patients when the first brain imaging 
study obtained was not a CT (n=14; Figure 1).  
Definitions 
 Brain imaging data were abstracted directly from radiology reports of the initial brain CT.  
A review of our coding algorithm is available as (Table 1). Stroke onset-to-initial CT time was 
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available in 57% of the cohort and indicated that 87% of studies were performed within 24 hours 
(Table 2). Based on a literature review and clinical practice, location of infarct, presence of 
edema, and any evidence of new or old hemorrhage were considered a priori as potential 
variables in the analysis.(8;9;13-17) As symptom onset cannot be reliably extracted from existing 
administrative data or unstructured chart review data, we did not take into account the time 
interval between symptom onset to brain imaging. Because infarct volume was not routinely 
available in radiology reports, we were unable to assess this variable. We based infarct location 
on: vascular distribution (e.g., middle cerebral artery [MCA]), individual lobe(s) involved (e.g., 
frontal), and other location (e.g., thalamus; see Figure 1). The variables that were considered in 
the analysis are listed under “Radiographic Findings” in Table 1. A rNIHSS was calculated for 
each patient from admission neurological examination data. We dichotomized stroke severity on 
the basis of the rNIHSS into mild/moderate (<10) and severe (≥10), as patients with severe 
strokes are less likely to have a better clinical outcome.  
Development and Validation 
 We divided the cohort into a random two-third sample for development, with the other 
one-third retained for validation. Logistic regression models with backward elimination were 
constructed in the development cohort to model both rNIHSS ≥10 and in-hospital mortality.  
When modeling rNIHSS ≥10, only two variables remained after backward elimination with a 
significance of p<0.05: hypodensities in the MCA distribution and in the temporal lobe. Presence 
of edema was the last variable eliminated at a p<0.0540. Because of this observed relationship to 
rNIHSS and because the previous literature has suggested that brain edema is associated with 
increased stroke severity, we initially kept the edema variable in the model.(8) However, the 
inclusion of edema did not improve discrimination of stroke severity; therefore we removed it 
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from the scoring system. We used the adjusted odds ratios (ORs) from the MCA and temporal 
lobe hypodensity variables to construct a scoring system that ranged from 0-3 (referred to in this 
manuscript as the Brain Imaging Score, or BIS; see Table 1 for listing of candidate radiographic 
variables). We then tested the BIS in our validation cohort. C-statistics were used to assess 
model performance.   
Missing data were rare; imputations were not made for missing data. All analyses were 
conducted using SAS 9.2 (Cary, North Carolina). Institutional Review Board (IRB) approval was 
obtained for this research.  
Results 
 Among the 1348 patients with a head CT, 1166 (86.5%) had an abnormal study; 
radiographic findings included focal hypodensity, edema, hemorrhage, and periventricular white 
matter disease (Table 3). Focal hypodensity (development: n=93 [10.2%]; validation: n=44 
[10.1%]) or edema (development: n=72 [7.9%]; validation: n=37 [8.6%]) occurred uncommonly. 
The development and validation sets were similar with regard to patient demographics, 
past medical history, proportion with severe stroke (35.2% versus 35.6%), the presence of 
edema, and in-hospital mortality (6.0% versus 7.6%) within tiers of NIHSS with the exception 
that patients in the development cohort with less severe stroke were more often male (65.0% vs. 
51.9%; p<0.0001). When comparing patients with mild/moderate versus severe strokes within 
the development set, patients with severe strokes were older (73.1 versus 70.5 years; p=0.004) 
with congestive heart failure (17.7% versus 10.6%;p=0.002), atrial fibrillation (27.0% versus 
15.0%; p<0.0001) and higher modified APACHE-III scores (12.4 versus 8.7; p<0.0001). 
Imaging obtained from patients with severe strokes more frequently demonstrated involvement 
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of: middle cerebral artery (16.5% versus 2.9%), parietal lobe (13.7% versus 5.6%), frontal lobe 
(11.8% versus 4.9%), temporal lobe (8.4% versus 2.2%; p<0.0001 for all).       
The timing from symptom onset to head CT was available in 763 patients. A fairly large 
proportion of patients received relative early CT scans after symptom onset. For example, 
patients with rNIHSS:<10 (n=453; 23.8%) and with rNIHSS≥10 (n=310;41.9%) received a head 
CT less than three hours from symptom onset (Table 2).  
The association between the BIS and both severe stroke (rNIHSS ≥10) and in-hospital 
mortality are shown in Table 2. As the BIS increased from 0 to 3, the proportion with severe 
strokes increased from 31.1% to 82.4% (p for trend=<0.0001) in the development set; a similar 
trend was observed in the validation cohort (31.6% to 66.7%;p for trend=<0.0001;Table 4). The 
gradient was monotonic in the development set but not in the validation set. As the BIS increased 
from 0 to 3, the proportion of patients dying during the hospital stay increased from 4.5% to 
23.5% (p for trend=<0.0001) in the development set; a similar trend was observed in the 
validation set (4.6% to 44.4%; p for trend=<0.0001); the gradient was also not monotonic in the 
validation set.  
The c-statistic for the BIS was similar between the development and the validation sets in 
modeling rNIHSS≥10 (0.581 and 0.579, respectively) and in-hospital mortality (0.623 and 0.678, 
respectively). By way of comparison, in this cohort, the c-statistic for the association of rNIHSS 
with in-hospital mortality was 0.84. 
Discussion 
 This study demonstrates that a simple approach based on radiographic findings on initial 
head CT provide considerable stroke severity stratification utilizing a few variables. Although 
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only a minority of patients had focal hypodensities on admission imaging, the BIS was 
associated with both severe strokes and in-hospital mortality.  
 Initial stroke severity, as measured by the NIHSS, strongly predicts important clinical 
measures as length of hospitalization, functional outcomes, discharge destination and 
mortality.(6;17) A minority of stroke patients receiving their care at VA (27.7%)(18) and Get With 
the Guidelines Stroke-Participating hospitals (45.1%)(4) had a documented NIHSS within the 
medical record, whereas stroke patients at these facilities commonly received brain imaging at 
presentation (95.0%).(18)  
Because the NIHSS or other validated measure of stroke severity are not typically 
available from administrative data, whereas the results from radiographic reports are routinely 
available, radiographic reports may be amenable to such data acquisition methods as natural 
language processing. Thus, radiographic-based approaches to estimating stroke severity may 
provide a feasible solution to the problem of not having a measure of stroke severity for risk 
adjustment in administrative data. Although some stroke patients have normal early head CT 
results, the prevalence of early ischemic changes on head CT has been reported to range from 
31% to 87%.(13;14) (19)  
Several studies have examined brain imaging findings on initial head CT and their 
prognostic utility in predicting stroke severity and mortality.(2;8) In the National Institute of 
Neurological Disorders and Stroke (NINDS) recombinant-tissue plasminogen activator (rt-PA) 
Trial, the authors found that early ischemic changes were associated with worse baseline 
NIHSS.(7) Further, the presence of edema or mass effect on initial head CT not only increased 
the risk of hemorrhagic conversion after rt-PA, but also increased mortality. Others have 
reported that as the degree of hypoattenuation or hypodensity increased, stroke severity 
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worsened.(9) In the European Cooperative Acute Stroke Study (ECASS), the presence and extent 
of a hypodensity on first head CT was associated with both severe disability. Using first head CT 
data from 12,550 participants in the International Stroke Trial, visible infarction independently 
predicted death within 14 days.(14) This prior work, demonstrating that head CT scan results can 
prognosticate outcomes, lends support to the notion that radiographic reports can serve as 
surrogates for stroke severity to be used in risk adjustment. 
 It is not surprising that radiographic infarcts within the MCA distribution (either alone or 
with temporal lobe involvement) were associated with both rNIHSS and mortality in our data.  
Many components of the NIHSS can be referred to lesions within the MCA distribution.(20)  
Vascular lesions visible within the MCA distribution via angiography are predictive of NIHSS 
scores ≥10.(21) Lesions on the CT scan within the MCA territory are associated with increased 
mortality, especially if more than one-third of its distribution is involved.(8) We were not able to 
comment in this study on the percentage of MCA involvement because this estimation was not 
routinely documented in radiographic reports.   
 The association between temporal lobe involvement and stroke severity, and especially 
the association with in-hospital mortality was relatively unexpected. Some previous studies have 
associated temporal lobe hypodensities with poor outcomes. For example, Kreiger et al found 
that the presence of a temporal lobe hypodensity was associated with increased risk of fatal brain 
swelling.(22) Also, right hemisphere insular cortex strokes have been associated with increased 
rates of arrhythmias and disinhibition of sympathetic control dampening, which may lead to 
higher mortality rates.(23;24)  
   Several limitations to this study are worth noting. First, the findings of this study only 
apply to an early head CT and not to other imaging modalities, such as Magnetic Resonance 
11 
 
Imaging (MRI). However, MRI is less frequently performed than head CT as the initial imaging 
modality when patients present for stroke evaluation. Following American Heart 
Association/American Stroke Association guidelines, most patients with acute neurological 
change and focal deficits receive a non-contrast CT scan as part of their initial evaluation; 
therefore, this is frequently accessible data.(6;14) Second, because of our sample size, we were 
unable to risk adjust for other important predictors of mortality. Therefore, our scoring system 
predictions of in-hospital mortality are unadjusted, and should be interpreted as such. Third, 
because radiology data were taken from radiology reports and images were not re-reviewed as 
part of this study, positive imaging findings may have been under or over-reported. Although CT 
scans are officially read by attending radiologists, some may have been read by general 
radiologists and others by neuroradiologists.  Inter-observer agreement regarding early signs of 
ischemic infarction is improved with level of training and experience; however, in routine 
practice, a general radiologist is more likely to read a head CT than a neuroradiologist.(10;14) 
Fourth, variability may exist in how findings are reported by a radiologist. For example, a given 
lesion could be correctly reported either as a focal hypodensity in the frontal lobe or in the MCA 
distribution. Fifth, the data analyzed were collected in 1998-2003, and current advances in CT 
imaging and radiological interpretation may result in more patients with evidence of infarct 
reported on initial head CT. Fifth, as described above, we do not have data on the extent of MCA 
involvement or the laterality of focal hypodensities, thereby limiting our ability to assess how 
these may be related to stroke severity.(8;23;24) Finally, the cohort only included patients with a 
rNIHSS of ≥2, therefore, future studies should confirm our findings in a cohort that also includes 
patients with a rNIHSS of 0 or 1.  
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Table 1: Coding Algorithm for Infarct Location 
Acute/subacute infarctions were coded from radiology reports.  All applicable locations were 
coded, and included the following: Middle cerebral artery (MCA), posterior cerebral artery 
(PCA), anterior cerebral artery (ACA), frontal lobe, temporal lobe, frontal lobe, occipital lobe, 
white matter, basal ganglia/internal capsule, thalamus, brainstem/cerebellum, other. 
A coding algorithm was also generated and is shown below. 
If chart states: Code: 
anterior choroidal artery (distribution)  basal ganglia/internal capsule 
calcarine cortex occipital lobe 
caudate head or caudate nucleus basal ganglia/internal capsule 
cerebellum brainstem/cerebellum 
cerebral peduncle brainstem 
Claustrum frontal & parietal lobes 
corpus callosum white matter 
corona radiata white matter 
extreme (external) capsule white matter 
globus pallidus basal ganglia/internal capsule 
Insula frontal & parietal lobes 
insular ribbon sign* (code Acute infarct) white matter + frontal 
lentiform nucleus basal ganglia 
loss of grey-white differentiation* white matter + geog. location 
MCA artery sign (code Acute infarct) middle cerebral artery 
Medulla brainstem/cerebellum 
midbrain  brainstem/cerebellum 
operculum frontal & parietal & temporal 
paracentral lobule  anterior cerebral artery 
periventricular/adjacent to ventricle white matter 
Pons brainstem 
post-central gyrus parietal lobe 
pre-central gyrus  frontal lobe 
Putamen basal ganglia/internal capsule 
semiovale (anterior, centrum or posterior) white matter 
splenum of corpus callosum white matter 
Striatum basal ganglia/internal capsule 
Subinsula frontal & parietal lobe 
transverse gyrus temporal lobe 
ventricular trigone white matter 
* For these processes, code white matter as well as any geographic location noted. 
 
 
 
16 
 
Table 2: Time from symptom onset to Head CT (N=763) 
Time NIHSS < 10 NIHSS ≥ 10 Total 
< 3 hours 108(23.8) 130(41.9) 238(31.2) 
3-6 hours 89(19.7) 61(19.7) 150(19.7) 
6-12 hours 95(21.0) 38 (12.3) 133(17.4) 
12-18 hours 59(13.0) 32(10.3) 91(11.9) 
18-24 hours 35(7.7) 20(6.5) 55(7.2) 
>24 hours 67(14.8) 29(9.4) 96(12.6) 
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Table 3.  Cohort Characteristics (N=1348)*  
 Development 
(N=916) † 
 Validation 
(N=432) ‡ 
 
Characteristic rNIHSS 
<10 
rNIHSS 
≥10 
P-value rNIHSS 
<10 
rNIHSS 
≥10 
P-value 
 N=594 N= 322  N=278 N=154  
Demographics       
Age (years): Mean (SD) 70.5(12.7) 73.1 (14.0) 0.004 70.5(13.3) 73.4(13.4) 0.03 
Race   0.17   0.64 
     White 469(79.0) 258(80.1)  213(76.6) 120(77.9)  
     Black 85(14.3) 50(15.5)  42(15.1) 27(17.5)  
     Hispanic 20(3.4) 10(3.1)  9(3.2) 3(2.0)  
     Other/unknown 20(3.4) 4(1.2)  14(5.0) 4(2.6)  
Male Gender 386(65.0) 167(51.9) 0.0001 151(54.3) 70(45.5) 0.08 
Past Medical History       
Prior stroke 153(25.8) 80(24.8) 0.76 71(25.5) 43(27.9) 0.60 
Prior TIA 96(16.2) 55(17.1) 0.72 49(17.6) 15(9.7) 0.03 
Hypertension 431(72.6) 229(71.1) 0.64 205(73.7) 106(68.8) 0.28 
Atrial Fibrillation 89(15.0) 87(27.0) <0.0001 42(15.1) 39(25.3) 0.009 
Myocardial infarction 100(16.8) 62(19.3) 0.36 35(12.6) 24(15.6) 0.39 
Congestive heart failure 63(10.6) 57(17.7) 0.002 27(9.7) 29(18.8) 0.007 
Diabetes 216(36.4) 90(28.0) 0.01 88(21.7) 42(27.3) 0.34 
Hyperlipidemia 189(31.8) 87(27.0) 0.13 82(29.5) 36(23.4) 0.17 
NIHSS: mean (SD) 5.2(2.1) 17.3(7.4) <0.0001 5.1(2.1) 17.0(6.3) <0.0001
Charlson comorbidity 
score: mean (SD) 
2.8(2.2) 3.2(2.5) 0.04 3.0(2.4) 3.0(2.5) 0.54 
Non-neurologic disease 
severity 
      
Modified APACHE III: 
mean (SD) 
17.6(8.7) 23.6 (12.4) <0.0001 17.3(8.1) 24.6(12.6) <0.0001
Independent in 
Activities of Daily 
Living 
498(83.8) 230(71.7) <0.0001 235(84.5) 114(74.0) 0.02 
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Radiographic Findings       
Edema 30(5.1) 42(13.0) <0.0001 16(5.8) 21(13.6) 0.005 
Infarct Locations       
Middle Cerebral Artery 17(2.9) 53(16.5) <0.001 9(3.2) 29(18.8) <0.0001
Posterior Cerebral 
Artery 
4(0.7) 2(0.6) 0.93 7(2.5) 1(0.6) 0.17 
Anterior Cerebral Artery 1(0.2) 2(0.6) 0.25 1(0.4) 0(0.0) 0.46 
Basal Ganglia 29(4.9) 21(6.5) 0.30 17(6.1) 11(7.1) 0.68 
Thalamus 5(0.8) 6(1.9) 0.18 1(0.4) 5(3.2) 0.01 
Parietal Lobe 33(5.6) 44(13.7) <0.0001 21(7.5) 13(8.4) 0.74 
Frontal 29(4.9) 38(11.8) <0.0001 13(4.7) 12(7.8) 0.18 
Temporal 13(2.2) 27(8.4) <0.0001 6(2.2) 8(5.2) 0.09 
Occipital 21(3.5) 16(5.0) 0.29 14(5.0) 5(3.2) 0.39 
Brainstem 18(3.0) 3(0.9) 0.04 8(2.9) 7(4.5) 0.36 
New hemorrhage 5(0.8) 3(0.9) 0.89 0(0.0) 2(1.3) 0.06 
No findings  
(normal CT) 
88(14.8) 39(12.1) 0.26 33(11.9) 19(12.3) 0.89 
In-hospital mortality  13(2.2) 42(13.0) <0.0001 4(1.4) 29(18.8) <0.0001
*Data are presented as number (column percentage) unless otherwise indicated. 
†P-values compare patients with NIHSS<10 to NIHSS≥10 within development set. 
‡P-values compare patients with NIHSS<10 to NIHSS≥10 within validation set. 
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Table 4. Association Data and Stroke Severity/In-hospital Mortality* 
  Development Cohort 
N=916 
Validation Cohort 
N= 432 
Brain Imaging 
Score 
Score rNIHSS 
<10 
rNIHSS 
≥10 
P-value † rNIHSS 
<10 
rNIHSS 
≥10 
P-value†
Neither MCA 
nor temporal 
lobe 
0 567(68.9) 256(31.1) <0.0001 266(68.4) 123(31.6) <0.0001 
Temporal lobe 
only 
1 10(43.5) 13(56.5)  3(60.0) 2(40.0)  
MCA only 2 14(26.4) 39(73.6)  6(20.7) 23(79.3)  
MCA and 
temporal lobe 
3 3(17.7) 14(82.4)  3(33.3) 6(66.7)  
Predicting  
In-Hospital 
Mortality‡ 
Score In-hospital 
survival 
In-hospital 
mortality 
P-value In-hospital 
survival 
In-hospital 
mortality 
P-value 
Neither MCA 
nor temporal 
lobe 
0 786(95.5) 37(4.5) <0.0001 371(95.4) 18(4.6) <0.0001 
Temporal lobe 
only 
1 21(91.3) 2(8.7)  4(80.0) 1(20.0)  
MCA only 2 41(77.4) 12(22.6)  20(69.0) 9(31.0)  
MCA and 
temporal lobe 
3 13(76.5) 4(23.5)  5(55.6) 4(44.4)  
        
*N (Row Percentage) 
† P-value for trend from Chi-Square test 
‡ Unadjusted mortality 
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Figure 1: Cohort Schematic (N=1363) 
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